epirubicine accord healthcare 2 mg/ml inj./inf. sol./i.vesic. sol. i.v. vial
accord healthcare b.v. - epirubicin hydrochloride 2 mg/ml - solution for injection/infusion; intravesical solution - 2 mg/ml - epirubicin hydrochloride 2 mg/ml - epirubicin
epirubicine teva 2 mg/ml inj./inf. sol. i.v. vial
teva pharma belgium sa-nv - epirubicin hydrochloride 2 mg - solution for injection/infusion - 2 mg/ml - epirubicin hydrochloride 2 mg/ml - epirubicin
epirubicine teva 2 mg/ml inj./inf. sol. i.v. vial
teva pharma belgium sa-nv - epirubicin hydrochloride 2 mg - solution for injection/infusion - 2 mg/ml - epirubicin hydrochloride 2 mg/ml - epirubicin
epirubicine teva 2 mg/ml inj./inf. sol. i.v. vial
teva pharma belgium sa-nv - epirubicin hydrochloride 2 mg - solution for injection/infusion - 2 mg/ml - epirubicin hydrochloride 2 mg/ml - epirubicin
epirubicine teva 2 mg/ml inj./inf. sol. i.v. vial
teva pharma belgium sa-nv - epirubicin hydrochloride 2 mg - solution for injection/infusion - 2 mg/ml - epirubicin hydrochloride 2 mg/ml - epirubicin
epirubicine teva 2 mg/ml inj./inf. sol. i.v. vial
teva pharma belgium sa-nv - epirubicin hydrochloride 2 mg - solution for injection/infusion - 2 mg/ml - epirubicin hydrochloride 2 mg/ml - epirubicin
dbl™ epirubicin hydrochloride
pfizer new zealand limited - epirubicin hydrochloride 2 mg/ml; - solution for injection - 2 mg/ml - active: epirubicin hydrochloride 2 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of: · breast cancer, · gastric cancer, · ovarian cancer, · small cell lung cancer, · lymphoma (non-hodgkin's lymphoma), · advanced/metastatic soft tissue sarcoma, and · superficial bladder cancer (tis; ta). in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3). epirubicin has also shown antitumour activity in the following tumours: · carcinoma of the oesophagus · primary hepatocellular carcinoma · pancreatic carcinoma · carcinoma of the head and neck · acute leukaemias and multiple myeloma
epirubicin hydrochloride 2mg/ml solution for injection or infusion solution for injection/infusion
accord healthcare limited - epirubicin (epirubicin hydrochloride) - solution for injection/infusion - 2mg/ml
epirubicin hydrochloride 2mg/ml solution for injection or infusion solution for injection/infusion
accord healthcare limited - epirubicin (epirubicin hydrochloride) - solution for injection/infusion - 2mg/ml
epirubicin hikma farmaceutica 2 mg/ml inj. sol. i.v. vial
hikma farmacêutica s.a. - epirubicin hydrochloride 2 mg/ml - solution for injection - 2 mg/ml - epirubicin hydrochloride 2 mg/ml - epirubicin